cover of episode Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the `Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104)

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the `Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104)

2013/5/1
logo of podcast Medizin - Open Access LMU - Teil 21/22

Medizin - Open Access LMU - Teil 21/22

Frequently requested episodes will be transcribed first

Shownotes Transcript

No transcript made for this episode yet, you may request it for free.